Literature DB >> 12578393

Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.

Jody M Havener1, Stephanie A Nick McElhinny, Ekaterina Bassett, Michele Gauger, Dale A Ramsden, Stephen G Chaney.   

Abstract

DNA polymerase mu (pol mu) is a member of the pol X family of DNA polymerases, and it shares a number of characteristics of both DNA polymerase beta (pol beta) and terminal deoxynucleotidyl transferase (TdT). Because pol beta has been shown to perform translesion DNA synthesis past cisplatin (CP)- and oxaliplatin (OX)-GG adducts, we determined the ability of pol mu to bypass these lesions. Pol mu bypassed CP and OX adducts with an efficiency of 14-35% compared to chain elongation on undamaged DNA, which is second only to pol eta in terms of bypass efficiency. The relative ability of pol mu to bypass CP and OX adducts was dependent on both template structure and sequence context. Since pol mu has been shown to be more efficient on gapped DNA templates than on primed single-stranded DNA templates, we determined the ability of pol mu to bypass Pt-DNA adducts on both primed single-stranded and gapped templates. The bypass of Pt-DNA adducts by pol mu was highly error-prone on all templates, resulting in 2, 3, and 4 nt deletions. We postulate that bypass of Pt-DNA adducts by pol mu may involve looping out the Pt-GG adduct to allow chain elongation downstream of the adduct. This reaction appears to be facilitated by the presence of a downstream "acceptor" and a gap large enough to provide undamaged template DNA for elongation past the adduct, although gapped DNA is clearly not required for bypass.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578393     DOI: 10.1021/bi0270079

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Translesion synthesis of acetylaminofluorene-dG adducts by DNA polymerase zeta is stimulated by yeast Rev1 protein.

Authors:  Dongyu Guo; Zhongwen Xie; Huiyun Shen; Bo Zhao; Zhigang Wang
Journal:  Nucleic Acids Res       Date:  2004-02-11       Impact factor: 16.971

Review 2.  Polymerases in nonhomologous end joining: building a bridge over broken chromosomes.

Authors:  Dale A Ramsden
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 3.  DNA polymerase family X: function, structure, and cellular roles.

Authors:  Jennifer Yamtich; Joann B Sweasy
Journal:  Biochim Biophys Acta       Date:  2009-07-23

4.  Co-inhibition of Pol η and ATR sensitizes cisplatin-resistant non-small cell lung cancer cells to cisplatin by impeding DNA damage repair.

Authors:  Xiao-Qin Li; Jin Ren; Ping Chen; Yu-Jiao Chen; Min Wu; Yan Wu; Kang Chen; Jian Li
Journal:  Acta Pharmacol Sin       Date:  2018-05-31       Impact factor: 6.150

Review 5.  DNA polymerase eta and chemotherapeutic agents.

Authors:  Kai-ming Chou
Journal:  Antioxid Redox Signal       Date:  2011-03-18       Impact factor: 8.401

Review 6.  Molecular mechanisms of resistance and toxicity associated with platinating agents.

Authors:  Cara A Rabik; M Eileen Dolan
Journal:  Cancer Treat Rev       Date:  2006-11-03       Impact factor: 12.111

7.  Lack of sugar discrimination by human Pol mu requires a single glycine residue.

Authors:  José F Ruiz; Raquel Juárez; Miguel García-Díaz; Gloria Terrados; Angel J Picher; Sergio González-Barrera; Antonio R Fernández de Henestrosa; Luis Blanco
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

Review 8.  Biological and therapeutic relevance of nonreplicative DNA polymerases to cancer.

Authors:  Jason L Parsons; Nils H Nicolay; Ricky A Sharma
Journal:  Antioxid Redox Signal       Date:  2012-09-05       Impact factor: 8.401

9.  Translesion DNA synthesis in the context of cancer research.

Authors:  Philip A Knobel; Thomas M Marti
Journal:  Cancer Cell Int       Date:  2011-11-02       Impact factor: 5.722

10.  Conferring a template-dependent polymerase activity to terminal deoxynucleotidyltransferase by mutations in the Loop1 region.

Authors:  Félix Romain; Isabelle Barbosa; Jérôme Gouge; François Rougeon; Marc Delarue
Journal:  Nucleic Acids Res       Date:  2009-06-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.